Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
6:07AMiHub NewswireFeaturedFifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates
06/14/20247:50AMGlobeNewswire Inc.Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-MarketNASDAQ:MREOMereo BioPharma Group PLC
06/14/20247:50AMGlobeNewswire Inc.Subsea7 awarded a contract for the Bittern field in the UK North SeaTG:SOCSubsea 7 SA
06/14/20247:50AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CNTXContext Therapeutics Inc
06/14/20247:50AMGlobeNewswire Inc.Treasure Global Inc Announces New Chief Executive OfficerNASDAQ:TGLTreasure Global Inc
06/14/20247:50AMGlobeNewswire Inc.Treasure Global Inc Announces New Chief Executive OfficerNASDAQ:VCIGVCI Global Ltd
06/14/20247:48AMPR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NEWS
06/14/20247:46AMPR Newswire (Canada)George Weston Limitée conclut un plan d'achat d'actions automatiqueTSX:WNGeorge Weston Ltd
06/14/20247:45AMPR Newswire (Canada)NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE INVESTMENT TRUST ANNOUNCES JUNE 2024 DISTRIBUTIONTSX:NWH.UNNorthwest Healthcare Properties Real Estate Investment Trust
06/14/20247:45AMPR Newswire (US)Consumer and Industry Advocates Highlight Measures to Counter Rise in Elder Real Estate Fraud and Financial Exploitation
06/14/20247:45AMPR Newswire (Canada)Decisive Dividend Corporation Announces July 2024 DividendTSXV:DEDecisive Dividend Corporation
06/14/20247:45AMPR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - NEWS
06/14/20247:42AMPR Newswire (Canada)George Weston Limited Enters into Automatic Share Purchase PlanTSX:WNGeorge Weston Ltd
06/14/20247:40AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
06/14/20247:40AMBusiness WireFuture Technologies Continues Energy Market Development with West Texas Office Expansion and Technology Showcase
06/14/20247:36AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
06/14/20247:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TWOU2U Inc
06/14/20247:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CODXCo Diagnostics Inc
06/14/20247:35AMBusiness WireEl programa de pruebas del Cessna Citation Ascend sigue adelante con el exitoso segundo artículo de prueba de vueloNYSE:TXTTextron Inc
06/14/20247:34AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNTXContext Therapeutics Inc
06/14/20247:34AMPR Newswire (US)Roy Jorgensen Associates, Inc. Receives Toyota Supplier of the Year Award
06/14/20247:32AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ITGRInteger Holdings Corporation
06/14/20247:30AMGlobeNewswire Inc.Plato Gold Welcomes Mr. Ernie J. Marcotte to the Board of DirectorsTSXV:PGCPlato Gold Corp
06/14/20247:30AMGlobeNewswire Inc.Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 CongressNASDAQ:IRONDisc Medicine Inc
06/14/20247:30AMGlobeNewswire Inc.Intellia Therapeutics Names Brian Goff to its Board of DirectorsNASDAQ:NTLAIntellia Therapeutics Inc
06/14/20247:30AMGlobeNewswire Inc.JOYY Inc. Announces the Results of the Repurchase Right Offer for its 1.375% Convertible Senior Notes due 2026NASDAQ:YYJOYY Inc
06/14/20247:30AMGlobeNewswire Inc.Phase 2 Findings Show Wugen’s Investigational Allogeneic CAR-T, WU-CART-007, Was Highly Effective and Surpassed Standard of Care in Treating Hard-to-Treat T-ALL/LBL; Data Presented Today at European Hematology Association (EHA) 2024 Hybrid Congress
06/14/20247:30AMGlobeNewswire Inc.Auction result of Treasury Bills - RIKV 24 0821 - RIKV 24 1218
06/14/20247:30AMGlobeNewswire Inc.Brixton Metals Appoints Patrick Highsmith to its Board of DirectorsTSXV:BBBBrixton Metals Corporation
06/14/20247:30AMGlobeNewswire Inc.Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evaluating Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)NASDAQ:COGTCogent Biosciences Inc

Your Recent History

Delayed Upgrade Clock